Education and knowledge transfer must be prioritized for industry to see sizable improvement in medical affairs.
Ailsa Budden
Advertisement
Senior Director, Global Medical Education—Oncology, Eli Lilly
Articles by Ailsa Budden
Advertisement
Latest Updated Articles
No Half Measures: How Medical Affairs Can Maximize and Measure ValuePublished: March 25th 2022 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
